Do Hydroxychloroquine and Ivermectin Work?
Five years after Donald Trump declared a national COVID-19 emergency, here's what the research says.
Five years after Donald Trump declared a national COVID-19 emergency, here's what the research says.
The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent.
The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.
A recent study finds that human challenge trials are largely safe.
Eliminating taxation on compensation for being a human guinea pig is just good public policy.
The omicron COVID-19 variant is likely to sweep through the country in the next month or so.
It's a good idea, but it should have been done much earlier.
But masks are still likely to prevent infected people from transmitting the virus.
Safe and effective vaccines by the end of this year?
The antimalarial drug is being removed from United Kingdom's RECOVERY trial evaluating COVID-19 therapies.
The observational dataset on which it was based could not be properly audited.
A major study in The Lancet said it doesn't—but it may have relied on fabricated data.
The World Health Organization pauses clinical trials in light of disturbing new results.
Volunteers would earn cash for the risks they take on our behalf.
Promising randomized controlled trial results indicate the drug shortens time to recovery
A contrast with last week's leaked results from a University of Chicago study
STAT reports leaked comments of University of Chicago researcher
"The best available evidence does not support the use of hydroxychloroquine in COVID-19."
An idea that could really speed up vaccine development
FDA is reportedly cutting red tape to give expanded access to COVID-19 patients.
MDMA, which was banned by the Drug Enforcement Administration in 1985, could be available by prescription as soon as 2021.
Slashing the restraints on the agency's slow and burdensome process.
What happens when cancer doctors, psychologists, and drug developers can't rely on each other's research?
"Right to try" laws offer hope for people trying to save their own lives.
Reason is an independent, audience-supported media organization. Your investment helps us reach millions of people every month.
Yes, I’ll invest in Reason’s growth! No thanksEvery dollar I give helps to fund more journalists, more videos, and more amazing stories that celebrate liberty.
Yes! I want to put my money where your mouth is! Not interestedSo much of the media tries telling you what to think. Support journalism that helps you to think for yourself.
I’ll donate to Reason right now! No thanksPush back against misleading media lies and bad ideas. Support Reason’s journalism today.
My donation today will help Reason push back! Not todayBack journalism committed to transparency, independence, and intellectual honesty.
Yes, I’ll donate to Reason today! No thanksSupport journalism that challenges central planning, big government overreach, and creeping socialism.
Yes, I’ll support Reason today! No thanksSupport journalism that exposes bad economics, failed policies, and threats to open markets.
Yes, I’ll donate to Reason today! No thanksBack independent media that examines the real-world consequences of socialist policies.
Yes, I’ll donate to Reason today! No thanksSupport journalism that challenges government overreach with rational analysis and clear reasoning.
Yes, I’ll donate to Reason today! No thanksSupport journalism that challenges centralized power and defends individual liberty.
Yes, I’ll donate to Reason today! No thanksYour support helps expose the real-world costs of socialist policy proposals—and highlight better alternatives.
Yes, I’ll donate to Reason today! No thanksYour donation supports the journalism that questions big-government promises and exposes failed ideas.
Yes, I’ll donate to Reason today! No thanksDonate today to fuel reporting that exposes the real costs of heavy-handed government.
Yes, I’ll donate to Reason today! No thanks